Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Biol Inorg Chem ; 24(8): 1197-1215, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31602542

RESUMO

Aberrant aggregation of the Aß protein is a hallmark of Alzheimer's disease (AD), but no complete characterization of the molecular level pathogenesis has been achieved. A promising hypothesis is that dysfunction of metal ion homeostasis, and consequently, the undesired interaction of metal ions with Aß, may be central to the development of AD. Qualitatively, most data indicate that Cu(II) induces rapid self-assembly of both Aß40 and Aß42 during the initial phase of the aggregation, while at longer time scales fibrillation may occur, depending on the experimental conditions. For Aß40 and Cu(II):Aß ≤ 1, most data imply that low concentration of Aß40 favors nucleation and rapid fibril elongation, while high concentration of Aß40 favors formation of amorphous aggregates. However, there are conflicting reports on this issue. For Aß42 and Cu(II):Aß ≤ 1, there is consensus that the lag time is extended upon addition of Cu(II). For Cu(II):Aß > 1, the lag time is increased upon interaction with Cu(II), and in most cases fibrillation is not observed, presumably because Cu(II) occupies a second more solvent-exposed binding site, which is more prone to form metal ion-bridged species and cause rapid formation of non-fibrillar aggregates. The interesting N-terminally truncated Aß11-40 with high affinity for Cu(II), exhibits delay of fibrillation upon addition of 0.4 eq. Cu(II). In our view, there are still problems achieving reproducible results in this field, and we provide a shortlist of some of the pitfalls. Finally, we propose a consensus model for the effects of Cu(II) on the aggregation kinetics of Aß.


Assuntos
Peptídeos beta-Amiloides/metabolismo , Cobre/metabolismo , Fragmentos de Peptídeos/metabolismo , Multimerização Proteica/efeitos dos fármacos , Sequência de Aminoácidos , Peptídeos beta-Amiloides/química , Humanos , Cinética , Fragmentos de Peptídeos/química , Conformação Proteica/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA